Developing generics and technologically complex products through focused teams in formulation and analytical development is Nexus Drugs’ core strength. Research and Development and Business Development work closely together to generate innovative concepts and ideas that exploit both market needs and synergies across therapeutic areas. From the product design to the manufacturing stage, we ensure quality by developing and applying skills. Based on Quality by Design (QbD) principles, formulation development enables the introduction of robust, reproducible and regulatory compliant products to the market. Developing technologically complex products is of top priority to us as a generic drug company. Our mission is to create strong differentiation by building and strengthening our capabilities. In the defined service areas, Nexus Drugs has developed a wide range of generic products including hard-to-copy formulations as well as immediate release formulations, modified release formulations, MUPS, nano products, etc.